COGNITIVE RESEARCH CORPORATION (CRC)
Purpose-built for bold CNS programs.
Cognitive Research Corporation (CRC) is a full-service, neuroscience-specialty CRO supporting biotechnology and pharmaceutical companies across Phase I-III clinical development. With 20 years of dedicated focus on CNS research, CRC brings deep scientific and operational expertise across neurology, psychiatry, and analgesia. CRC’s integrated clinical operations, biometrics, scientific, medical, and assessments teams work alongside a long-standing network of CNS-focused research sites to support high-quality data, informed decision-making, and consistent execution from study startup through closeout.
For more information, visit our website and follow us on LinkedIn.
FEATURED ARTICLES
-
A 2026 executive order is fast-tracking psychedelic therapies for depression, PTSD, and addiction. Understand what this regulatory shift means for your next clinical trial.
-
Metabolic drugs show promise for brain disorders. Emerging evidence suggests they reduce addictive behaviors and may help treat neurodegenerative diseases, opening new pathways for addiction and neurological care.
-
Discover how clinical trial protocols are evolving to address unblinding, therapeutic support variables, and regulatory standards in modern psychedelic research.
-
Vague warning labels leave patients and prescribers guessing about driving safety. Discover recent compliance data and learn how simulation studies clarify real-world functional risk.
-
Central nervous system (CNS) trials are rapidly evolving. Learn how fit-for-purpose protocol design, centralized eligibility review, and novel modalities elevate clinical success.
CONTACT INFORMATION
Cognitive Research Corporation (CRC)
200 Central Ave, Ste. 1200
St. Petersburg, FL 33701
UNITED STATES
Phone: (727) 897 ext. 9000
FEATURED PRODUCTS AND SERVICES
-
Screen failures, dropouts, and protocol deviations start with the wrong participants. A holistic eligibility review process helps get enrollment right the first time.
-
Struggling with rater consistency or endpoint selection in your schizophrenia trial? Learn how deep neuroscience expertise safeguards data quality and drives faster decisions.
-
Psychedelic trials demand rare expertise. See how the right team tackles regulatory hurdles, site readiness, and protocol design to keep your study moving forward.
-
Running a migraine trial? Learn how specialized neuroscience support, from PRO selection to real-time data review, can resolve common study delays and endpoint gaps.
-
Early phase trials demand speed and precision. Discover a partnership providing specialized expertise that keeps your program on track.
-
Discover how validated simulation studies help clarify real-world safety risks before approval.
-
A structured data lifecycle from protocol design to database lock keeps trial data clean, compliant, and ready for regulatory submission.
-
If tight clinical timelines are putting your Alzheimer's program under pressure, understanding what full-service neuroscience support looks like is the right place to start.
-
If rater quality is a risk your study can't afford to take, now is the time to evaluate whether your current approach has the structure to support it.
-
Explore how dedicated brain and nervous system research support, deep disease expertise, and operational rigor can optimize your clinical trial's success.
CASE STUDIES
-
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Enrollment hesitancy, staff turnover, and compressed timelines threatened a multi-phase Alzheimer's program. Learn the operational approach that delivered results at every stage.
-
Parallel trials, compressed timelines, thousands of patients. Discover the data oversight strategies that kept two programs on track to approval